Patent · US Expired

Sequestrin of Plasmodium falciparum

US6310046A · kind A · utility

12Cited by
3References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 17, 1995
Grant dateOct 30, 2001
Priority date
Expiry dateNov 17, 2015

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

In this application is described the expression cloning and functional characterization of the CD36-binding domain of Sequestrin. Sequestrin is a surface protein of 215-250 kD size which does not vary in size between parasite strains. The Sequestrin gene appears to be single-copy-number within the genome; noncytoadherent laboratory parasite strains carry the sequestrin gene but fail to express the protein. Sequestrin binds with high affinity to CD36. Sequestrin protein and sequence can be used as a diagnostic, prognostic, and therapeutic tool.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.